A Biopharma A-List Lineup Aims To Tackle Complex Manufacturing At Resilience

 
• By Jessica Merrill

Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.

Dispensing fluid into test tubes
Resilience aims to tackle big manufacturing hurdles • Source: Shutterstock

More from Manufacturing

More from Business